# A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

> **NCT03830528** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** KW-6356 Low Dose
- **DRUG:** KW-6356 Middle Dose
- **DRUG:** KW-6356 High Dose
- **DRUG:** KW-6356 X Dose
- **DRUG:** KW-6356 Y Dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03830528
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-26
- **Primary completion:** 2019-10-10
- **Final completion:** 2019-10-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03830528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03830528, "A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03830528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*